Camber Pharmaceuticals, Inc recalls Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceutical…
- Recall date
- December 6, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0094-2023
- FDA classification
- Class III
- Brand / firm
- Camber Pharmaceuticals, Inc
- Sold / distributed
- USA Nationwide
Why it was recalled
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26
Get recall alerts
Free email alert whenever Camber Pharmaceuticals, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Camber Pharmaceuticals, Inc